The financial terms of the acquisition were not disclosed.
According to ZS, the acquisition paves the way for offerings that will help drive the success and scale of digital health solutions and virtual care services.
Medullan provides healthcare solutions through its virtual care platform, VARA, and its digital medicine solution design and development. According to the company, it works with payers, health services companies, and life sciences companies to build solutions that create business value and a positive impact on their customers.
“The power and flexibility of Medullan’s platform and other capabilities – combined with ZS’s deep business expertise, industry relationships, and global reach – mean that we’re able to help our clients overcome digital delivery barriers and improve patient outcomes in this unprecedented moment,” said Chris Wright, CEO at ZS.
Chris Wright added: “The COVID-19 pandemic has accelerated patient acceptance and industry need for scalable, secure, reliable, and seamless digital health solutions.”
“Digital health solutions will transform how we experience healthcare, improve lives and reduce costs in the process. While significant progress has been made, there remain many challenges to overcome toward realizing this vision,” said Pete Masloski, principal at ZS and leader of the DCH practice, which Medullan employees will join.
“Together, we will be in a unique position – with deep digital health expertise and capabilities from strategy through execution – to help our clients create impact at scale in digital health,” said Dharmendra Sahay, principal and global leader of technology and analytics at ZS who also serves as the board sponsor of the DCH practice.
A total of 63 digital health companies were acquired in Q1 2021, compared to 52 in Q4 2020, according to Mercom’s Q1 2021 Digital Health Funding and M&A Report. According to the Mercom digital health M&A database, nearly 2,000 digital health companies have been acquired/merged since 2010. Learn more.